DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/8365Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zaripov S.I. Abdurakhmanova N.M. Pulotova S.A. | - |
| dc.date.accessioned | 2023-06-13T05:49:49Z | - |
| dc.date.available | 2023-06-13T05:49:49Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Тошкент | en_US |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/8365 | - |
| dc.description.abstract | Systemic sclerosis is a chronic autoimmune connective tissue disease, characterized by endothelial dysfunction, immune abnormalities and progressive fibrosis of skin and multiple inner organs. The main marker of an abnormal immune response is circulating autoantibodies, which are found in more than 95% of patients with systemic sclerosis. It is important to study the clinical, immunological, diagnostic and prognostic significance of autoantibodies, especially anti-fibrillarin antibodies produced against the fibrillarin protein. | en_US |
| dc.language.iso | en | en_US |
| dc.subject | To study the clinical significance of anti-fibrillarin (U3-RNP) antibodies in systemic sclerosis. | en_US |
| dc.title | The clinical significance of anti-fibrillarin (u3-rnp) antibodies in systemic sclerosis | en_US |
| dc.type | Thesis | en_US |
| Appears in Collections: | Thesis, Articles | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Zaripov S.I. tezis.pdf | The clinical significance of anti-fibrillarin (u3-rnp) antibodies in systemic sclerosis | 592.38 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.